2026/03/17 更新

写真a

ノモト ユウタロウ
野元 裕太朗
NOMOTO Yutaro
所属
医歯学域附属病院 附属病院 診療センター 循環器センター 特任助教
職名
特任助教
 

論文

  • Shinden Y., Eguchi Y., Toda H., Nagata A., Oyabu A., Nakao R., Hayashi N., Nomoto Y., Minami K., Hirashima T., Kawasaki Y., Sasaki K., Yoshinaka H., Owaki T., Tanimoto A., Ohtsuka T., Nakajo A. .  Prognostic Evaluation of the Charlson Comorbidity Index for Breast Cancer Patients by Propensity Score Matching Analysis .  Journal of Breast Cancer29 ( 1 ) 33 - 42   2026年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:Journal of Breast Cancer  

    Purpose: The Charlson Comorbidity Index (CCI) is associated with the prognosis of patients with breast cancer. However, comorbidities are often confounded by both age and treatment course; therefore, it is essential to eliminate the influence of these factors. We analyzed the relationship between CCI scores and breast cancer prognosis using propensity score matching (PSM). Methods: We retrospectively analyzed 1,403 patients with primary breast cancer who underwent curative surgery. After PSM, 764 patients were selected for analysis of clinicopathological and prognostic factors. Results: After PSM, prognosis was compared between groups according to several CCI cutoff values. No significant differences in disease-free survival or breast cancer-specific overall survival (OS) were observed according to the CCI score. Similarly, no significant differences in OS were observed between the high-and low-CCI groups at CCI cutoff values of 1 and 2. However, at a CCI cutoff value of 3, OS was significantly worse in patients with higher CCI scores. Conclusion: Among patients with breast cancer, those with CCI scores ≥ 3 often experience mortality due to diseases other than breast cancer.

    DOI: 10.4048/jbc.2025.0051

    Scopus

    PubMed

  • 伊東 伸洋, 神田 大輔, 横峯 辰生, 野元 裕太朗, 田端 宏之, 下野 洋和, 大牟禮 健太, 窪薗 琢郎, 大石 充 .  石灰化結節病変に対しIntravascular lithotripsy(IVL)による処置後に薬剤溶出性ステント留置し、その後の経過が良好であった1例 .  日本心臓病学会学術集会抄録73回   713 - 713   2025年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本心臓病学会  

  • Nomoto Y, Mukai M, Eguchi Y, Yoshinaka H, Shinden Y, Nakajo A .  A Case of Grade 4 Hyperglycemia Induced by Capivasertib and Successfully Managed with Early Insulin Intervention. .  Surgical case reports11 ( 1 )   2025年

     詳細を見る

    記述言語:英語  

    DOI: 10.70352/scrj.cr.25-0514

    PubMed

  • Shimono H., Kanda D., Tokushige A., Ito N., Nomoto Y., Tabata H., Ohmure K., Kubozono T., Ohishi M. .  Association between the modified Japanese Version of High Bleeding Risk scores and clinical outcomes in Japanese patients with lower extremity artery disease undergoing endovascular treatment .  Heart and Vessels   2025年

     詳細を見る

    記述言語:日本語   出版者・発行元:Heart and Vessels  

    This study aimed to investigate the association between the modified Japanese Version of High Bleeding Risk (J-HBR) criteria and the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria with clinical outcomes in patients with lower extremity artery disease (LEAD) undergoing endovascular treatment (EVT). We enrolled 305 consecutive patients with LEAD who underwent EVT. Each modified J-HBR and ARC-HBR score was calculated by assigning 1 and 0.5 points to each major and minor criterion, respectively. Coronary artery disease was included as a major criterion in the modified J-HBR criteria, replacing peripheral vascular disease. The cut-off values for ARC-HBR and modified J-HBR scores were determined using the survival classification and regression tree (CART) model to predict all-cause mortality. A novel bleeding risk score associated with major bleeding events was developed from this dataset, with its cut-off determined by the CART model. The primary outcome was all-cause mortality; the secondary outcome was major bleeding events defined as Bleeding Academic Research Consortium type 3 or 5 following EVT. We also compared the discriminatory ability of the modified J-HBR, ARC-HBR, and novel bleeding risk scores. During a median follow-up of 1085 (435–1951) days, 116 patients died and 36 had major bleeding events. The CART model classified patients into low (modified J-HBR < 2, ARC-HBR < 1, novel bleeding risk 0), intermediate (modified J-HBR 2–2.5, ARC-HBR 1–1.5, novel bleeding risk 1), and high (modified J-HBR ≥ 3, ARC-HBR ≥ 2, novel bleeding risk ≥ 2) risk groups. Kaplan–Meier curves demonstrated a significant increase in mortality with higher modified J-HBR and ARC-HBR scores (log-rank p < 0.001) and in major bleeding events with higher novel bleeding risk scores (log-rank p < 0.001). Time-dependent receiver operating characteristic analysis for 1- and 3-year all-cause mortality showed modified J-HBR had a higher area under the curve (AUC) than ARC-HBR at 1 year (0.72 vs. 0.66, p = 0.040) and 3 years (0.66 vs. 0.61, p = 0.024). The novel bleeding risk score tended to have a higher AUC for predicting major bleeding events at 1 year than modified J-HBR (0.77 vs. 0.69, p = 0.068) and ARC-HBR (0.77 vs. 0.67, p = 0.067). The modified J-HBR and ARC-HBR scores effectively stratified the mortality risk, whereas the novel bleeding risk score effectively stratified bleeding risk in patients with LEAD undergoing EVT. The modified J-HBR score demonstrated superior discriminative ability in predicting mid- and long-term mortality compared to the ARC-HBR score.

    DOI: 10.1007/s00380-025-02629-0

    Scopus

    PubMed

  • Shinden Y., Nomoto Y., Nagata A., Eguchi Y., Yano H., Saho H., Hayashi N., Minami K., Hirashima T., Sasaki K., Yoshinaka H., Owaki T., Nakajo A., Ohtsuka T. .  Clinical effectiveness of microporous polysaccharide hemospheres in mastectomy for patients with breast cancer .  Gland Surgery13 ( 3 ) 307 - 313   2024年

     詳細を見る

    記述言語:日本語   出版者・発行元:Gland Surgery  

    Background: Microporous polysaccharide hemospheres (MPH) are hydrophilic particles administered to reduce the incidence of seroma after mastectomy, but their clinical effectiveness remains controversial. Because a previous randomized, controlled study in a small cohort could not demonstrate the effectiveness of MPH in breast surgery, we evaluated their effectiveness in surgery for breast cancer in a larger cohort. Methods: Medical records of 352 patients who underwent total mastectomy for breast cancer were retrospectively reviewed. Clinical data were compared between 126 patients who received MPH during surgery (MPH group) and 226 who did not (control group) according to surgical procedures. Patients were significantly older in the MPH group than in the control group because of selection bias, but other factors, such as body mass index and number of dissected lymph nodes, did not differ between groups. Results: When analyzed by use of axillary manipulation, the drain placement period and drainage volume were significantly less in the MPH group than in the control group for patients with mastectomy and sentinel lymph node biopsy. Only drainage volume was significantly less in the MPH group for patients with mastectomy and axillary lymph node dissection. The frequency of total postoperative complications, such as seroma requiring puncture, did not differ between groups. Conclusions: Use of MPH may decrease the postoperative drainage volume and drain placement period in mastectomy for patients with breast cancer.

    DOI: 10.21037/gs-23-297

    Scopus

    PubMed

  • Kataoka Tetsuro, Fukunaga Kengo, Hiramine Kiyohisa, Nomoto Yutaro, Matsumoto Hiroyuki, Sonoda Kohichiro, Okino Hideto, Tagata Kento, Kumamoto Kengo, Kubota Yui, Baba Yoshimasa, Takasaki Kunitsugu, Nakashima Hitoshi, Tanaka Yasuhiro, Tokushige Akihiro, Ohishi Mitsuru .  症候性重症大動脈弁狭窄症患者に対するSAPIEN 3 20mmによる経カテーテル大動脈弁留置術後の2年間の臨床成績 最小サイズとそれよりも大きな経カテーテル大動脈弁の比較(Two-Year Clinical Outcomes Following SAPIEN 3 20-mm Transcatheter Aortic Valve Implantation in Patients with Symptomatic Severe Aortic Stenosis-Comparison of the Smallest Size Valve against Larger Transcatheter Aortic Valve) .  Journal of Transcatheter Valve Therapies6 ( 1 ) 103 - 111   2024年

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本経カテーテル心臓弁治療学会  

    経カテーテル大動脈弁留置術植込み術(TAVI)は、症候性重度大動脈弁狭窄症を有する高齢患者や高リスク外科患者の主要な治療法である。本研究では、当施設で広く使用されている最小サイズのバルーン拡張型経カテーテル心臓弁(THV)であるSAPIEN 3 20mmの安全性と有効性を後ろ向きに評価した。2017年6月~2022年10月に単施設でSAPIEN 3によるTAVIを受けた患者456例を、20mm THV群56例(女性98.2%、平均84.6±5.0歳)、23mm THV群254例(女性82.3%、平均85.5±4.3歳)、26/29mm THV群146例(女性25.3%、平均84.5±4.7歳)に分け、短期成績、有害事象、新規ペースメーカー植込み(PMI)、弁周囲漏出(PVL)、人工臓器患者不適合(PPM)、30日死亡率、2年死亡率を比較した。その結果、20mm THV群では新規PMIや中等度以上のPVLは観察されなかったが、中等度PPMの発生率は他群より有意に高かった。2年全死亡率には有意差が認められなかった。結論として、20mm THVの短期転帰は概ね良好であり、中等度PPMの増加は見られたものの、長期予後への影響は限定的である可能性が示唆された。

  • Kataoka Tetsuro, Fukunaga Kengo, Hiramine Kiyohisa, Nomoto Yutaro, Matsumoto Hiroyuki, Sonoda Kohichiro, Okino Hideto, Tagata Kento, Kumamoto Kengo, Kubota Yui, Baba Yoshimasa, Takasaki Kunitsugu, Nakashima Hitoshi, Tanaka Yasuhiro, Tokushige Akihiro, Ohishi Mitsuru .  Two-Year Clinical Outcomes Following SAPIEN 3 20-mm Transcatheter Aortic Valve Implantation in Patients with Symptomatic Severe Aortic Stenosis—Comparison of the Smallest Size Valve against Larger Transcatheter Aortic Valve .  Journal of Transcatheter Valve Therapies6 ( 1 ) 103 - 111   2024年

     詳細を見る

    記述言語:英語   出版者・発行元:Japan Transcatheter Valve Therapies  

    <p><b>Objective:</b> Transcatheter aortic valve implantation (TAVI) has become a cornerstone treatment for elderly or high-risk surgical patients with symptomatic severe aortic stenosis. The continuous evolution of TAVI techniques and technology has significantly improved its safety and efficacy. This study aims to deepen our understanding of the safety and effectiveness of the smallest size balloon-expanding transcatheter heart valve (BE-THV): SAPIEN 3 20 mm, through extensive utilization at our institution, with the goal of further refining TAVI procedures in the future.</p><p><b>Methods:</b> This retrospective single-center observational study included 456 consecutive patients who underwent TAVI with SAPIEN 3 valves between June 2017 and October 2022. The short-term outcomes, adverse events such as stroke, new pacemaker implantation (PMI), paravalvular leak (PVL), prosthesis-patient mismatch (PPM), 30-day mortality, and 2-year mortality associated with the 20-mm THV were analyzed and compared with those of the 23-mm THV or the 26-/29-mm THV.</p><p><b>Results:</b> The most commonly used THV size was 23 mm, accounting for 55.7% (254 cases), followed by the 26-/29-mm THV at 32.0% (146 cases) and the 20-mm THV at 12.3% (56 cases). There were no instances of new PMI or moderate or severe PVL observed in the 20-mm THV group. The 30-day mortality rate was 1.8% in patients who underwent the 20-mm THV, 1.6% in those with the 23-mm THV, and 0% in those with the 26-/29-mm THV, with no significant difference observed (P = 0.3012). However, the incidence of moderate PPM in patients who underwent the 20-mm THV implantation was 24.1% (13 out of 55), compared to 5.3% in those with the 23-mm THV and 4.3% in those with the 26-/29-mm THV, showing a statistically significant increase (P <0.0001), but severe PPM was not observed in any THV groups. The prevalence of a postprocedural transvalvular mean pressure gradient (MPG) ≥20 mmHg in the 20-mm THV group was higher compared to other size groups (20 mm: 14.3% vs. 23 mm: 2.0% vs 26/29 mm: 1.4%, P <0.0001). There was no significant difference in 2-year all-cause mortality rates (20 mm: 14.3% vs. 23 mm: 11.5% vs. 26/29 mm: 9.7%, P = 0.6491) among the different THV sizes.</p><p><b>Conclusion:</b> The short-term outcomes associated with the 20-mm THV were reasonably satisfactory. While the occurrence of moderate PPM was significantly higher in patients receiving the 20-mm THV compared to other THV sizes, there were no significant differences in the 2-year mortality rate.</p>

    DOI: 10.33290/jtvt.oa.24-0001

    CiNii Research

  • 沖野 秀人, 片岡 哲郎, 野元 裕太朗, 福永 研吾, 高崎 州亜, 中島 均, 大石 充 .  造影剤使用後に第1世代薬剤溶出性ステントで血栓症を生じたKounis症候群の1例 .  日本心臓病学会学術集会抄録71回   P - 13   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本心臓病学会  

  • 片岡 哲郎, 沖野 秀人, 福永 研吾, 野元 裕太朗, 中島 均 .  右心カテーテル検査の際に肺動脈損傷をきたしカバードステントを使用してベイルアウトした閉塞性肥大型心筋症患者の1例 .  日本心血管インターベンション治療学会抄録集31回   MP71 - 3   2023年8月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本心血管インターベンション治療学会  

  • Shinden Y., Kamimura K., Hayashi N., Nomoto Y., Nagata A., Eguchi Y., Yano H., Saho H., Nakajo A., Minami K., Hirashima T., Sasaki K., Yoshinaka H., Owaki T., Tanimoto A., Nakamura M., Ohtsuka T. .  Relationship between Delayed Breast Cancer Diagnosis and Behavioral Economic Factors and Personality Characteristics .  Asian Pacific Journal of Cancer Prevention24 ( 10 ) 3437 - 3440   2023年

     詳細を見る

    記述言語:日本語   出版者・発行元:Asian Pacific Journal of Cancer Prevention  

    Background: Delays in breast cancer diagnosis can allow the disease to progress to an incurable stage. However, factors that cause patients to delay seeking treatment are unclear. In this study, we aimed to identify behavioral economic factors and personality characteristics of patients with breast cancer who had a delayed diagnosis. Methods: We analyzed questionnaires completed by 41 patients with breast cancer. A delayed diagnosis was defined if the time between the first symptom and the medical visit was more than 6 months. Results: We found 11 patients who had a delayed diagnosis. The significant characteristics associated with patients with breast cancer who had delayed diagnosis were: (i) less experience with breast cancer screening; (ii) progressive disease stage; and (iii) low time and future time preference. We found no significant behavioral economic factors other than time preference, and personality that differed between patients with breast cancer who did and did not have a delayed diagnosis. Conclusion: Low time preference rate is a characteristic of patients with breast cancer who had a delayed diagnosis.

    DOI: 10.31557/APJCP.2023.24.10.3437

    Scopus

    PubMed

  • Nagata A, Shinden Y, Nomoto Y, Saho H, Nakajo A, Minami K, Kumagae Y, Kirishima M, Owaki T, Ohtsuka T .  Metastasis of breast cancer to the right kidney with a tumor thrombus in the inferior vena cava: a case report. .  Surgical case reports8 ( 1 ) 13   2022年1月

     詳細を見る

    記述言語:英語  

    DOI: 10.1186/s40792-022-01364-2

    PubMed

  • Eguchi Y, Yoshinaka H, Hayashi N, Sueyoshi K, Uchikura K, Nomoto Y, Nagata A, Saho H, Shinden Y, Ohtsuka T .  Accessory breast cancer in the inframammary region: a case report and review of the literature. .  Surgical case reports7 ( 1 ) 203   2021年9月

     詳細を見る

    記述言語:英語  

    DOI: 10.1186/s40792-021-01285-6

    PubMed

  • 尾辻 秀章, 榎園 圭, 野元 裕太朗, 剣田 昌伸, 木原 浩一 .  ルリッシュ症候群を合併した急性動脈閉塞の症例 .  日本心血管インターベンション治療学会抄録集29回   879 - 879   2021年2月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本心血管インターベンション治療学会  

  • Nakajo A., Minami K., Shinden Y., Hirashima T., Saho H., Nomoto Y., Nagata A., Ohtsuka T. .  The usefulness and utilization of a detachable steel wire-rimmed retractor (KN retractor) for endoscopic thyroid and parathyroid surgery .  Surgery Today51 ( 1 ) 159 - 164   2021年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:Surgery Today  

    Purpose: In endoscopic surgery, surgeons occasionally encounter difficulties due to visual field obstruction by muscles or blood vessels. In these situations, specialized instruments that can effectively retract these obstructions are required. Recently, we developed a new detachable wire-rimmed retractor (KN retractor) for narrow-space surgery. Methods: We evaluated the utility of this KN retractor in 15 patients with thyroid and parathyroid disease. Of those, five patients with papillary thyroid cancer had gasless endoscopic hemithyroidectomy with central node dissection, five underwent endoscopic total thyroidectomy for Graves’ disease, and the remaining five received endoscopic parathyroidectomy with gas insufflation. Results: Surgeons were able to perform meticulous operations in a satisfactory visual field supported by the KN retractor. In all patients, the strap muscles were preserved without cutting. The average operating time was 149, 154, and 81 min in patients who underwent hemithyroidectomy with central node dissection, total thyroidectomy, and parathyroidectomy, respectively. Gas insufflation was successfully completed in all cases while maintaining sufficient airtightness. Conclusions: The KN retractor is suitable for both the gasless lifting method and gas insufflation surgery in a narrow space. We believe that the KN retractor is a new device that will greatly improve the safety and shorten the operation time in endoscopic surgery.

    DOI: 10.1007/s00595-020-02124-1

    Scopus

    PubMed

▼全件表示

MISC

講演・口頭発表等

  • 大牟禮 健太, 神田 大輔, 伊東 伸洋, 野元 裕太朗, 田端 宏之, 下野 洋和, 窪薗 琢郎, 大石 充 .  血管内治療後の下肢動脈疾患患者における低栄養・炎症・アテローム性動脈硬化因子の併存が予後に及ぼす影響(Impact of Co-presence of Malnutrition-Inflammation-Atherosclerosis Factors on Prognosis in Lower Extremity Artery Disease Patients after Endovascular Therapy) .  日本循環器学会学術集会抄録集  2025年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 野元 裕太朗, 神田 大輔, 伊東 伸洋, 田端 宏之, 下野 洋和, 大牟禮 健太, 窪薗 琢郎, 大石 充 .  血管内治療を受ける下肢閉塞性動脈疾患患者における血清コリンエステラーゼが包括的高度慢性下肢虚血(CLTI)の転帰に及ぼす影響(The Impact of Serum Cholinesterase on CLTI Outcomes in LEAD Patients Undergoing Endovascular Therapy) .  日本循環器学会学術集会抄録集  2025年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 下野 洋和, 神田 大輔, 伊東 伸洋, 野元 裕太朗, 田端 宏之, 大牟禮 健太, 大石 充 .  血管内治療を受ける下肢動脈疾患患者における術前血清コリンエステラーゼ値が臨床転帰に及ぼす影響 .  日本心血管インターベンション治療学会抄録集  2025年7月  (一社)日本心血管インターベンション治療学会

     詳細を見る

    記述言語:英語  

  • 野元 裕太朗, 神田 大輔, 伊東 伸洋, 田端 宏之, 下野 洋和, 大牟禮 健太, 窪薗 琢郎, 大石 充 .  血管内治療を受けるCLTI合併および非合併下肢閉塞性動脈疾患患者におけるスタチンの差異的効果(Differential Effects of Statins in LEAD Patients with and without CLTI Undergoing EVT) .  日本循環器学会学術集会抄録集  2025年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 片岡 哲郎, 福永 研吾, 野元 裕太朗, 田方 健人, 沖野 秀人, 隈元 健吾, 窪田 唯伊, 平峯 聖久, 園田 幸一郎, 松本 洋之, 馬場 善政, 高崎 州亜, 東 健作, 薗田 正浩, 中島 均, 田中 康博 .  経カテーテル的大動脈弁留置術を受けた90歳以上の患者における術後成績と短期予後の評価(Assessment of Procedure Outcomes and Short-term Prognosis in Patients Aged 90 and Elder Undergoing Transcatheter Aortic Valve Implantation) .  日本循環器学会学術集会抄録集  2024年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 伊東 伸洋, 神田 大輔, 野元 裕太朗, 田端 宏之, 下野 洋和, 大牟禮 健太, 大石 充 .  心房細動を伴わないLEAD患者におけるCHADS2スコアとGNRIの複合評価が予後に与える影響 .  日本心血管インターベンション治療学会抄録集  2025年7月  (一社)日本心血管インターベンション治療学会

     詳細を見る

    記述言語:英語  

  • 福永 研吾, 片岡 哲郎, 沖野 秀人, 野元 裕太朗, 高崎 州亜, 中島 均, 大石 充 .  当院における狭小弁輪に対するSapien3を用いたTAVRの治療成績 .  日本心臓病学会学術集会抄録  2023年9月  (一社)日本心臓病学会

     詳細を見る

    記述言語:日本語  

  • 福永 研吾, 片岡 哲郎, 福崎 篤, 野元 裕太朗, 平峯 聖久, 薗田 正浩, 中島 均, 大石 充 .  当院における「CHIP TAVI」3症例の検討 .  日本心血管インターベンション治療学会抄録集  2023年8月  (一社)日本心血管インターベンション治療学会

     詳細を見る

    記述言語:英語  

  • 福永 研吾, 片岡 哲郎, 窪田 唯伊, 隈元 健吾, 田方 健人, 沖野 秀人, 松本 洋之, 野元 裕太朗, 園田 幸一郎, 馬場 善政, 平峯 聖久, 高崎 州亜, 薗田 正浩, 中島 均, 田中 康博, 大石 充 .  大動脈弁輪が小さい大動脈弁狭窄症患者に対する20mmバルーン拡張型経カテーテル心臓弁留置術の実現可能性(The Feasibility of 20-mm Balloon-Expandable Transcatheter Heart Valve Implantation in Aortic Stenosis Patients with Small Aortic Annulus) .  日本循環器学会学術集会抄録集  2024年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 大牟禮 健太, 神田 大輔, 伊東 伸洋, 野元 裕太朗, 田端 宏之, 下野 洋和, 窪薗 琢郎, 大石 充 .  低栄養を伴う下肢動脈疾患患者におけるガイドライン準拠薬物療法が予後に及ぼす影響(Impact of Guideline-Directed Medical Therapy on Prognosis in Malnourished Patients with Lower Extremity Artery Disease) .  日本循環器学会学術集会抄録集  2025年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 田方 健人, 片岡 哲郎, 窪田 唯伊, 隈元 健吾, 沖野 秀人, 松本 洋之, 野元 裕太朗, 園田 幸一郎, 馬場 善政, 福永 研吾, 平峯 聖久, 高崎 州亜, 薗田 正浩, 中島 均, 田中 康博, 大石 充 .  バルーン拡張型経カテーテル心臓弁を用いた経カテーテル的大動脈弁留置術における血管合併症の早期および短期予後への影響(Impact of Vascular Complication during Transcatheter Aortic Valve Implantation with Balloon Expandable Transcatheter Heart Valve on Early and Short-term Prognosis) .  日本循環器学会学術集会抄録集  2024年3月  (一社)日本循環器学会

     詳細を見る

    記述言語:英語  

  • 片岡 哲郎, 福永 研吾, 野元 裕太朗, 田方 健人, 隈元 健吾, 窪田 唯伊, 平峯 聖久, 園田 幸一郎, 松本 洋之, 馬場 善政, 高崎 州亜, 大石 充 .  TAVI施行患者における2年予後の影響因子の検証 .  日本心臓病学会学術集会抄録  2024年9月  (一社)日本心臓病学会

     詳細を見る

    記述言語:日本語  

▼全件表示